Tempest Therapeutics, Inc. (TPST) Technical Analysis

🔺 Technical Setup

📊 Technical Summary

Tempest Therapeutics, Inc. (TPST) closed at 1.96 (-12.50%). Price remains below both the 50-day and 200-day moving averages, which keeps the broader technical backdrop under pressure until stronger recovery signals appear. 20-day momentum is notably weak at -9.26%, with price is trading in the lower part of its roughly 52-week range (1.52–11.83), while ATR14 volatility is elevated at roughly 11.03% of price. RSI(14) is 49.2, leaving momentum in a fairly neutral range. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD remains above its signal line, which keeps the momentum structure biased to the upside. The MACD histogram remains positive, although upside momentum is not accelerating further. From a pattern perspective, the main active signal is Double top. Nearby upside pressure sits around 2.25. A decisive move through that level would improve the short-term picture. Latest fundamentals snapshot: Revenue: 67,000 · Net income: -3.51M · EPS (basic): -0.79. The interactive view adds overlays, pattern context and broader chart structure for deeper review.

Explore more